SEC Form 4 · accession 0001607062-15-000187
GENEREX BIOTECHNOLOGY CORP · GNBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P Barratt
Director
Period of report
Apr 27, 2015
Accepted (ET)
Apr 27, 2015 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001059784
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2015 | M | 5,874,162 | $0.001 | A | 5,874,162 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Purchase Option (right to buy) | $0.001 | Apr 27, 2015 | M | 918,033 | D | Jun 19, 2012 | Jun 19, 2017 | Common Stock | 918,033 | 0 | D |
| Common Stock Purchase Option (right to buy) | $0.001 | Apr 27, 2015 | M | 2,553,191 | D | Apr 1, 2013 | Apr 1, 2018 | Common Stock | 2,553,191 | 0 | D |
| Common Stock Purchase Option (right to buy) | $0.001 | Apr 27, 2015 | M | 592,593 | D | Jun 6, 2013 | Jun 6, 2018 | Common Stock | 592,593 | 0 | D |
| Common Stock Purchase Option (right to buy) | $0.001 | Apr 27, 2015 | M | 1,810,345 | D | Jan 1, 2014 | Oct 31, 2018 | Common Stock | 1,810,345 | 0 | D |